Atomo Diagnostics Ltd's (ASX:AT1) John Kelly and Will Souter speak to Proactive's Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. Atomo's an Australian-headquartered medical device company with a sole focus on improving point-of-care diagnostics and delivering what they describe as a much more 'consumer-friendly and fit-for-purpose solution' in the community.
Atomo Diagnostics with Proactive at the ASX Small and Mid-Cap Conference 2020
Quick facts: Atomo Diagnostics Ltd
Price: 0.35 AUD
Market Cap: $196.82 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE